课题基金 / 基金详情

The expression of HSP47 and the antisense therapy in the atherosclerosis animal model

The expression of HSP47 and the antisense therapy in the atherosclerosis animal model
动脉粥样硬化动物模型中HSP47的表达及反义治疗
批准号:
14570678
负责人:
OZONO Yoshiyuki
金额:
$1.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

OZONO Yoshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The relationship between the progression of atherosclerosis and HSP47. was examined in ApoE knockout mouse as the animal model of atherosclerosis. The arterial walls of he animals were examined about the development of atherosclerosis at the aging ranging from 5 weeks to 28 weeks. Gross examination by dissection microscopy revealed the acculation of macrophage, the formation of atherom, foam cell lesion after 22 weeks mouse.The HSP47 expression in the arterial walls in the ApoE knockout mouse were assessed by immunostaining (Anti HSP 47 monoclonal antibody : Stressgen Biotechnolpgies Corp, Victoia BC, Canada). The HSP47 expression and the collagenI were evident in the arteriosclerotic lesions after 22weeks AopE knockout mouse.The antisense ODNs against HSP47 was administrated in the vein in the ApoE knockout mouse tail in order to suppress the progression of atherosclerosis.But the uptake of this antisense was not efficient for the purpose of atherosclerosis treatment in this animal model. The elnew strategy for the HSP47 antisense therapy in this model.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
西野友哉, 大園恵幸他: "Antisense oligonucleotid against collagen binding stress protein HSP47 suppress Peritoneal fibrosis in rats"Kidney International. 64. 887-896 (2003)
Tomoya Nishino、Keiyuki Ozono 等人:“抗胶原结合应激蛋白 HSP47 的寡核苷酸抑制大鼠腹膜纤维化”《肾脏国际》64. 887-896 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomoya Nishino, Yoshiyuki Ozono et al.: "Antisense oligonucleotides against-binding stress protein HSP47 suppress peritoneal fibrosis in rats."Kidney Internatinal. 64. 887-896 (2003)
Tomoya Nishino、Yoshiyuki Ozono 等人:“针对结合应激蛋白 HSP47 的反义寡核苷酸可抑制大鼠腹膜纤维化。”Kidney Interatinal。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A NEW THERAPEUTIC STRATEGY FOR PERITONEAL SCLEROSIS ; USE OF ANTISENSE OLIGONUCLEOTIDES (ODN) AGAINST HSP47 IN RAT CHLORHEXIDINE GLUCONATE MODEL
  • 批准号:
    11671039
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.15万
  • 财政年份:
    1999
  • 负责人:
    OZONO Yoshiyuki
  • 依托单位:
国内基金
海外基金
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
  • 批准号:
    91957111
  • 项目类别:
    重大研究计划
  • 资助金额:
    80.0万元
  • 批准年份:
    2019
  • 负责人:
    李佩盈
  • 依托单位:
高尿酸血症促进动脉粥样硬化机制探讨
  • 批准号:
    81170251
  • 项目类别:
    面上项目
  • 资助金额:
    14.0万元
  • 批准年份:
    2011
  • 负责人:
    刘梅林
  • 依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
  • 批准号:
    81070247
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2010
  • 负责人:
    秦树存
  • 依托单位:
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
  • 批准号:
    81000086
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    江立生
  • 依托单位: